REHOVOT, Israel, July 11, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its financial results for the second quarter of 2019 on Wednesday, July 31, 2019.

LONDON, July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs), one of the most common meniscal tears affecting approximately one-third of patients with this injury.

ALBUQUERQUE, N.M., July 11, 2019 /PRNewswire/ -- Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract from the National Institutes of Health's National Center for the Advancement of Translational Sciences, for the study of Sickle Cell Disease (SCD).  SCD is an autosomal recessive disorder that affects a large number of African-Americ

INDIANAPOLIS, July 11, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the New England Journal of Medicine published positive Phase 3 study results of Emgality® (galcanezumab-gnlm) for the treatment of episodic cluster headache.1 In this study, Emgality reduced the frequency of weekly clus

STOCKHOLM, July 11, 2019 /PRNewswire/ -- The James M. Slater, MD Proton Treatment and Research Center at Loma Linda University Medical Center, US, has chosen the treatment planning system (TPS) RayStation®* to replace its existing systems for photon and proton therapy planning, following a tender process. The James M. Slater,

NEW YORK and TORONTO, July 11, 2019 /PRNewswire/ - CBD For Life (the "Company"), a subsidiary of

NEW YORK, July 11, 2019 /PRNewswire/ -- A new report from WebMD finds that while grief is nearly universal, most people feel rushed to "get over it," and find social media posts about their loss among the least helpful responses from others during the grieving process.

NEW YORK, July 11, 2019 /PRNewswire/ -- LabFinder.com, the convenient online platform for patients to schedule their laboratory and radiology tests and access test results, has announced an API in

EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it

MONTGOMERY, Ala., July 11, 2019 /PRNewswire/ -- H2-Pharma, LLC, a privately held pharmaceutical company, announced today that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive U.S. distributor of ETOPOPHOS® (etoposide phosphate) for injection. This opportunity arose due to its successful partnership with CHEPLAPHARM Arzneimittel